Tower Research Capital (TRC)’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-2,478
| Closed | -$1K | – | 6555 |
|
2023
Q1 | $1K | Buy |
+2,478
| New | +$1K | ﹤0.01% | 5725 |
|
2022
Q2 | – | Sell |
-1,092
| Closed | -$8K | – | 6832 |
|
2022
Q1 | $8K | Buy |
1,092
+284
| +35% | +$2.08K | ﹤0.01% | 4649 |
|
2021
Q4 | $5K | Buy |
808
+117
| +17% | +$724 | ﹤0.01% | 5240 |
|
2021
Q3 | $8K | Sell |
691
-1,388
| -67% | -$16.1K | ﹤0.01% | 4594 |
|
2021
Q2 | $39K | Buy |
2,079
+2,019
| +3,365% | +$37.9K | ﹤0.01% | 3249 |
|
2021
Q1 | $1K | Buy |
+60
| New | +$1K | ﹤0.01% | 5253 |
|
2017
Q4 | – | Sell |
-9
| Closed | -$4K | – | 4283 |
|
2017
Q3 | $4K | Sell |
9
-20
| -69% | -$8.89K | ﹤0.01% | 3428 |
|
2017
Q2 | $17K | Buy |
+29
| New | +$17K | ﹤0.01% | 1324 |
|
2016
Q2 | – | Sell |
-4
| Closed | -$2K | – | 5158 |
|
2016
Q1 | $2K | Buy |
4
+3
| +300% | +$1.5K | ﹤0.01% | 3490 |
|
2015
Q4 | $1K | Sell |
1
-1
| -50% | -$1K | ﹤0.01% | 4212 |
|
2015
Q3 | $3K | Buy |
+2
| New | +$3K | ﹤0.01% | 3198 |
|
2015
Q2 | – | Sell |
-2
| Closed | -$2K | – | 5246 |
|
2015
Q1 | $2K | Buy |
+2
| New | +$2K | ﹤0.01% | 3863 |
|
2014
Q4 | – | Sell |
-18
| Closed | -$24K | – | 4894 |
|
2014
Q3 | $24K | Buy |
18
+12
| +200% | +$16K | ﹤0.01% | 2167 |
|
2014
Q2 | $9K | Buy |
6
+3
| +100% | +$4.5K | ﹤0.01% | 2467 |
|
2014
Q1 | $6K | Sell |
3
-2
| -40% | -$4K | ﹤0.01% | 3148 |
|
2013
Q4 | $11K | Buy |
+5
| New | +$11K | ﹤0.01% | 2928 |
|